35301 |
Dermatology |
A Split-Face, Single-Blinded, Randomized Controlled Comparison of 532 ... |
ANN DERMATOL 2020 10.5021/ad.2020.32.1.8 |
김원석 |
2020 |
35300 |
Biochemistry & Molecular Biology; Chemistry, Multidisciplinary |
HB-EGF Improves the Hair Regenerative Potential of Adipose-Derived Ste... |
INT J MOL SCI 2020 10.3390/ijms21010122 |
김원석 |
2020 |
35299 |
Hematology |
Plasma cell-free DNA is a prognostic biomarker for survival in patient... |
ANN HEMATOL 2020 10.1007/s00277-020-04008-3 |
김원석 |
2020 |
35298 |
Pathology |
Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and... |
MODERN PATHOL 2020 10.1038/s41379-019-0392-8 |
김원석 |
2020 |
35297 |
Oncology; Hematology |
Treatment of mantle cell lymphoma in Asia: a consensus paper from the ... |
J HEMATOL ONCOL 2020 10.1186/s13045-020-00855-9 |
김원석 |
2020 |
35296 |
Hematology |
Survival outcomes of patients with extranodal natural-killer T-cell ly... |
Lancet Haematol 2020 10.1016/S2352-3026(19)30283-2 |
김원석 |
2020 |
35295 |
Hematology |
Survival outcomes for extranodal natural-killer T-cell lymphoma |
Lancet Haematol 2020 |
김원석 |
2020 |
35294 |
Oncology |
Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Ex... |
CANCER RES TREAT 2020 10.4143/crt.2019.198 |
김원석 |
2020 |
35293 |
Hematology |
A phase II study of ibrutinib in combination with rituximab-cyclophosp... |
ANN HEMATOL 2020 10.1007/s00277-020-04005-6 |
김원석 |
2020 |
35292 |
Oncology |
Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients... |
BMC CANCER 2020 10.1186/s12885-020-6612-2 |
김원석 |
2020 |